Wound Debridement Products Market - By Product (Enzymatic, Autolytic (Gels, Ointments), Mechanical, Surgical, Ultrasonic), By Wound Type (Diabetic Foot Ulcers, Venous Leg, Pressure Ulcers, Burns), Application (Hospitals, Clinics) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030

Wound Debridement Products Market held USD 611.8 million in 2020 and is to grow with a CAGR of 9% from 2020-2030. Wound debridement is the process of extracting infected tissue from a wound, dead tissue, and foreign substances. Wound debridement helps reduce diverse types of microbes, toxins and other extraneous substances which inhibit wound healing. The market of wound debridement products can be classified into selective methods and non-selective methods depending on the process of debridement. Selective methods include the treatment of larvae debriding or bio-chirurgical deposit, the treatment of autolytic and enzyme or chemical deposits. Mechanical debridement, ultrasound, sharp and practical debridement are non-selective methods.

Market Dynamics and Factors:

The growth in the wound debridement products market is driven by factors such as the rising incidence of diabetes and the related accidents, growing rate of activity and an increasing geriatric population. Rate of diabetes incidence is increasing at all ages mainly because of obesity, poor diet and physical inactivity. The number of chronic injuries, in particular foot ulcers, is increasing among the diabetic population and the use of wound debridement has been increased. The insistence on improved care choices and the immense burden of illnesses is therefore expected to drive the demand in wound debridement. However high treatment cost is expected to subdue market growth to some extent.

Market Segmentation:

Based on the type of disease, the wound debridement products market industry is segmented into enzymatic, autolytic, mechanical, surgical, ultrasonic and others. Autolytic is segmented into Gels and Ointments. Based on wound type, the market is segmented into diabetic foot ulcers, venous leg, pressure ulcers, burns. On the basis of application, the wound debridement products market trends vary into hospitals pharmacies, others. Geographical breakdown and analysis of each of the aforementioned segments includes regions comprising North America, Europe, Asia-Pacific, and RoW.

Geographic Analysis:

The growing incidence of diabetes, high enzyme debridement penetration and large market acting presence in the industry in North America can be attributed to the growth. However, in the forecast period, Asia Pacific is expected to register the highest CAGR. The presence of a large number of the patient population and the growing awareness of advanced products are driving wound debridement products  market growth in this region.

Competitive Scenario:

Global wound debridement products market, is garnered by few of the major players which control majority of the market. Key companies are also expanding their manufacturing facilities to cater to growing demand for this therapy. Key players enhancing the global Wound Debridement Products market size include DeRoyal Industries (US), Smith & Nephew, B. Braun Melsungen AG, Coloplast, ConvaTec, Mölnlycke Healthcare, Lohmann & Rauscher, Integra Lifesciences, Arobella Medical, LLC, Advancis Medical (UK), RLS Global (Sweden).

Smith & Nephew offers a wide range of wound debridement products, such as surgical devices, gels, and ointments. Owing to its well-established product range and popular brand image, the company maintains its leading place in the wound debridement market. In addition, the company has maintained presence in more than 100 countries around the globe. Also, the company has well-established distribution channels in developed markets such as the US. In 2019 alone, it generated about 50% of its revenue from the US.

Wound Debridement Products Market Report Scope